2025-05-02 09:06:12
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Fredun Pharmaceuticals posts net profit of Rs. 1.87 crore in Q3FY22
Posted On : 2022-01-28 19:53:01( TIMEZONE : IST )
Fredun Pharmaceuticals Ltd has reported Standalone financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 54.2325 crores during the period ended December 31, 2021 as compared to Rs. 54.7624 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 1.8716 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 1.8397 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 4.22 for the period ended December 31, 2021 as compared to Rs. 4.61 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 54.2325 crs | ₹54.7624 crs |  -0.97% |
| Net Profit | ₹1.8716 crs | ₹1.8397 crs |  1.73% |
| EPS | ₹4.22 | ₹4.61 | -8.46% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 54.2325 crores during the period ended December 31, 2021 as compared to Rs.45.5678 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.1.8716 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.1.3366 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.4.22 for the period ended December 31, 2021 as compared to Rs.3.35 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 54.2325 crs | ₹45.5678 crs | 19.01% |
| Net Profit | ₹1.8716 crs | ₹1.3366 crs | 40.03% |
| EPS | ₹4.22 | ₹3.35 | 25.97% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.154.2443 crores during the 9 Months period ended December 31, 2021 as compared to Rs.92.9102 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.4.0396 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.2.1993 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.10.13 for the 9 Months period ended December 31, 2021 as compared to Rs.5.51 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹154.2443 crs | ₹92.9102 crs | 66.01% |
| Net Profit | ₹4.0396 crs | ₹2.1993 crs | 83.68% |
| EPS | ₹10.13 | ₹5.51 | 83.85% |
Shares of Fredun Pharmaceuticals Ltd was last trading in BSE at Rs. 1091.50 as compared to the previous close of Rs. 1064.45. The total number of shares traded during the day was 4906 in over 207 trades.
The stock hit an intraday high of Rs. 1114.50 and intraday low of 1011.25. The net turnover during the day was Rs. 5268303.00.
